Sign In to Follow Application
View All Documents & Correspondence

Lanifibranor For Use In The Treatment Of Splanchnic Vasodilatation In A Patient With A Liver Condition

Abstract: The present invention relates to the use of lanifibranor or a deuterated form thereof or a pharmaceutical acceptable salt thereof for the treatment of splanchnic vasodilatation in a patient with a liver condition.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
01 December 2025
Publication Number
51/2025
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

INVENTIVA
50 rue de Dijon 21121 DAIX

Inventors

1. WETTSTEIN, Guillaume
50 rue de Dijon DAIX 21121
2. JUNIEN, Jean-Louis
122 Boulevard Haussmann 75008 Paris
3. LEFERE, Sander
Corneel Heymanslaan 10 9000 Ghent
4. HELDENS, Anneleen
Corneel Heymanslaan 10 9000 Ghent
5. GEERTS, Anja
Corneel Heymanslaan 10 9000 Ghent

Specification

Documents

Application Documents

# Name Date
1 202517119719-STATEMENT OF UNDERTAKING (FORM 3) [01-12-2025(online)].pdf 2025-12-01
2 202517119719-REQUEST FOR EXAMINATION (FORM-18) [01-12-2025(online)].pdf 2025-12-01
3 202517119719-PROOF OF RIGHT [01-12-2025(online)].pdf 2025-12-01
4 202517119719-PRIORITY DOCUMENTS [01-12-2025(online)].pdf 2025-12-01
5 202517119719-POWER OF AUTHORITY [01-12-2025(online)].pdf 2025-12-01
6 202517119719-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [01-12-2025(online)].pdf 2025-12-01
7 202517119719-FORM 18 [01-12-2025(online)].pdf 2025-12-01
8 202517119719-FORM 1 [01-12-2025(online)].pdf 2025-12-01
9 202517119719-DRAWINGS [01-12-2025(online)].pdf 2025-12-01
10 202517119719-DECLARATION OF INVENTORSHIP (FORM 5) [01-12-2025(online)].pdf 2025-12-01
11 202517119719-COMPLETE SPECIFICATION [01-12-2025(online)].pdf 2025-12-01